A new model of experimental subretinal neovascularization in the rabbit.

Existing animal models of choroidal neovascularization (CNV) present several problems: they are hard to reproduce, they are inefficient, and the CNV created is not sustainable. The purpose of this study is to develop a highly efficient, reliable, sustainable rabbit model of CNV to facilitate the study of anti-angiogenic and anti-proliferative therapies for ocular diseases. Twenty-two pigmented rabbits were used in this study. Eleven rabbits received subretinal injections of either 10 microl of Matrigel with 500 ng of vascular endothelial growth factor (VEGF) or 20 microl of Matrigel with 750 ng of VEGF; eight rabbits received subretinal injections of either 10 or 20 microl of Matrigel only; three rabbits used as controls received subretinal injections of 20 microl phosphate-buffered saline (PBS) alone. Fundus photography, fluorescein angiography, optical coherence tomography, and histologic examinations were performed 1, 2, 4, and 9 weeks after injection. All experimental eyes showed angiographic leakage within this localized area 1 week after injection. The amount of leakage usually increased at weeks 2 and 4 and, in most cases, persisted at week 9. Control eyes demonstrated no leakage at any time point. Optical coherence tomography of treated eyes showed subretinal fluid and the presence of a lesion, possibly vascular or fibrotic, at the site of the leakage. Histologic analysis confirmed the presence of new subretinal blood vessels in the areas of Matrigel deposit. In conclusion, this novel method provides a highly reproducible, reliable, and sustainable rabbit model of experimental choroidal neovascularization. Such a model may prove useful for screening new anti-angiogenic therapies in a larger animal eye.

[1]  P. Campochiaro,et al.  VEGF‐TRAPR1R2 suppresses choroidal neovascularization and VEGF‐induced breakdown of the blood–retinal barrier , 2003 .

[2]  C. Grindle,et al.  Ageing changes in Bruch's membrane and their functional implications. , 1978, Transactions of the ophthalmological societies of the United Kingdom.

[3]  S. Seregard,et al.  Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.

[4]  R. Auerbach,et al.  The sponge/Matrigel angiogenesis assay , 2004, Angiogenesis.

[5]  B. Halliwell.  Oxidants and human disease: some new concepts 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  M. Perrot-Applanat,et al.  VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. , 2005, Experimental cell research.

[7]  W. Manning,et al.  AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. , 2003, Investigative ophthalmology & visual science.

[8]  P. Penfold,et al.  Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. , 1986, Investigative ophthalmology & visual science.

[9]  D. Hinton,et al.  Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[10]  J D Gottsch,et al.  Oxidative damage and age-related macular degeneration. , 1999, Molecular vision.

[11]  S. Ryan.  De novo subretinal neovascularization in the histoplasmosis syndrome. , 1976, Archives of ophthalmology.

[12]  M. Detmar,et al.  Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Hollick,et al.  Radiotherapy treatment of age-related subfoveal neovascular membranes in patients with good vision , 1996, Eye.

[14]  P. Campochiaro,et al.  Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.

[15]  F. Ferris,et al.  Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.

[16]  P. Campochiaro,et al.  VEGF is major stimulator in model of choroidal neovascularization. , 2000, Investigative ophthalmology & visual science.

[17]  Y Ikada,et al.  A new model of subretinal neovascularization in the rabbit. , 1995, Investigative ophthalmology & visual science.

[18]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[19]  D. Eliott,et al.  Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.

[20]  S. Ryan,et al.  Subretinal neovascularization. Natural history of an experimental model. , 1982, Archives of ophthalmology.

[21]  C. Frennesson,et al.  Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration. , 2004, Acta ophthalmologica Scandinavica.

[22]  M. Bartoli,et al.  Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. , 2005, Current drug targets.

[23]  B. Ehinger,et al.  Graft-host connections in long-term full-thickness embryonic rabbit retinal transplants. , 1999, Investigative ophthalmology & visual science.

[24]  Y. Iwamoto,et al.  Role of Basement Membranes in Cell Differentiation , 1987, Annals of the New York Academy of Sciences.

[25]  D. Hinton,et al.  Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.

[26]  Richard F Spaide,et al.  Lipid hydroperoxide stimulates subretinal choroidal neovascularization in the rabbit. , 2002, Experimental eye research.

[27]  Nasim Akhtar,et al.  Angiogenesis assays: a critical overview. , 2003, Clinical chemistry.

[28]  P. Penfold,et al.  An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. , 1984, Australian journal of ophthalmology.

[29]  S. Ryan,et al.  SUBRETINAL ENDOPHOTOCOAGULATION: A New Model of Subretinal Neovascularization in the Rabbit , 1991, Retina.

[30]  P. Campochiaro,et al.  Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. , 1998, The American journal of pathology.

[31]  K. Takahashi,et al.  Optical coherence tomography (OCT) findings in normal retina and laser-induced choroidal neovascularization in rats , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  G. Lip,et al.  Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. , 2001, Ophthalmology.

[33]  Joan W. Miller,et al.  Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. , 2002, Investigative ophthalmology & visual science.

[34]  P. Campochiaro,et al.  Retinal and choroidal neovascularization , 2000, Journal of cellular physiology.

[35]  S. C. Lee,et al.  Choroidal neovascularization characteristics and its size in optical coherence tomography. , 2003, Yonsei medical journal.

[36]  P. Penfold,et al.  Senile macular degeneration: The involvement of immunocompetent cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[37]  J. Oh,et al.  The possibility of gene therapy for the treatment of choroidal neovascularization. , 2000, Ophthalmology.

[38]  T. Ishibashi,et al.  Morphologic observations on experimental subretinal neovascularization in the monkey. , 1987, Investigative ophthalmology & visual science.

[39]  G. Soubrane,et al.  Etiology of choroidal neovascularization in young patients. , 1996, Ophthalmology.

[40]  George A. Williams,et al.  VARIABILITY IN FLUORESCEIN ANGIOGRAPHY INTERPRETATION FOR PHOTODYNAMIC THERAPY IN AGE-RELATED MACULAR DEGENERATION , 2002, Retina.

[41]  R. Frank,et al.  A model of subretinal neovascularization in the pigmented rat. , 1989, Current eye research.

[42]  P. Campochiaro,et al.  Intravitreal Sustained Release of VEGF Causes Retinal Neovascularization in Rabbits and Breakdown of the Blood– Retinal Barrier in Rabbits and Primates , 1997 .

[43]  H. Kleinman,et al.  Malignant transformation of NIH‐3T3 cells after subcutaneous co‐injection with a reconstituted basement membrane (matrigel) , 1992, International journal of cancer.

[44]  T. Shigeno,et al.  A novel concept on the pathogenetic mechanism underlying ischaemic brain oedema: relevance of free radicals and eicosanoids. , 1987, Acta neurochirurgica. Supplementum.

[45]  B. Ehinger,et al.  Long-term full-thickness embryonic rabbit retinal transplants. , 1999, Investigative ophthalmology & visual science.

[46]  Paul S. Bernstein,et al.  Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration , 1997 .

[47]  A. K. Chung,et al.  Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. , 2005, Ophthalmology.

[48]  F. Bandello,et al.  Optical coherence tomography of subfoveal choroidal neovascularization treated with transpupillary thermotherapy , 2001, Seminars in ophthalmology.

[49]  Y. Tabata,et al.  Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination. , 2002, Investigative ophthalmology & visual science.

[50]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[51]  M. Mandai,et al.  Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model. , 1999, Investigative ophthalmology & visual science.